Lv3
282 积分 2022-10-10 加入
HER2-targeted therapies beyond breast cancer — an update
10小时前
已完结
Lung cancer
1天前
已完结
Antibody–drug conjugates come of age in oncology
1天前
已完结
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
1天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
3天前
已完结
PARP Inhibitors for Breast Cancer Treatment
4天前
已完结
Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements
7天前
已完结
Cleavable linkers in antibody–drug conjugates
9天前
已完结
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
9天前
已完结
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
9天前
已完结
皖公网安备34019202002308
